American Century Companies’s Akero Therapeutics AKRO Stock Holding History

American Century Companies's AKRO Position: Q4 2025 in Review

American Century Companies sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 663,442 shares — an estimated $31.5M sold.

American Century Companies first reported a position in AKRO in Q4 2022 and held it in 6 quarters. The position peaked at $31.5M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

• American Century Companies reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
• American Century Companies sold 663,442 Akero Therapeutics shares in Q4 2025, an estimated $31.5M.
• American Century Companies first reported a position in Akero Therapeutics in Q4 2022 and held it in 6 quarters.
• American Century Companies's Akero Therapeutics position peaked at $31.5M in Q3 2025.
• 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.